• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

International Stem Cell Corp

+ Add to Watchlist


0.075 EUR 0.0000.00%

As of 02:01:36 ET on 09/18/2014.

Snapshot for International Stem Cell Corp (0IS)

Open: 0.075 Day's Range: 0.075 - 0.075 Volume: 0
Previous Close: 0.075 52wk Range: 0.042 - 0.216 1-Yr Rtn: -25.00%

Stock Chart for 0IS

No chart data available.
  • 0IS:GR 0.075
  • 1D
  • 1M
  • 1Y
Interactive 0IS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 0IS

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.0500
Est. PEG Ratio -
Market Cap (M EUR) 16.02
Shares Outstanding (M) 213.59
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/13/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 0IS

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for 0IS

International Stem Cell Corporation develops therapeutic and research products in the biotechnology industry. The Company seeks to use human cells for use in the treatment of several diseases including diabetes, as well as in liver and retinal diseases.

Andrey SemechkinCo-Chairman/CEOJay Tibor NovakCFO/Dir:Finance/Secy
Ruslan SemechkinChief Scientific OfficerJohn Simon CrawExec VP:Bus Dev
More Company Profile & Key Executives for 0IS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil